SMAD4 and familial pancreatic carcinoma: Several lines of evidence showed that Smad4 may act as a tumor suppressor in colorectal cancer (Ogawa et al., 2019; Wasserman et al., 2018; Yan et al., 2016) and pancreatic cancer (Blackford et al., 2009; Xu et al., 2010).